#breast cancer — Tuesday, September 01, 2026 (2 items)
| 0 | ℹ |
Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial.
(nature.com)
|
Nature Medicine 2026-09-01 | #clinical trial #immunotherapy #breast cancer #neoadjuvant #checkpoint inhibitor | |
| 0 | ℹ |
Single-cell multi-omic profiling of heterogeneous PROCR(+) cells in mouse mammary gland and its implication for breast cancer.
(linkinghub.elsevier.com)
|
iScience 2026-09-01 | #transcriptomics #single-cell #breast cancer #stemness #chromatin |